Michel Mélac

Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5–grass pollen tablet for seasonal allergic rhinitis

A. Didier, Hans‐Jørgen Malling, Margitta Worm et al. · Journal of Allergy and Clinical Immunology · 2007 · 485 citations

Asthma, Allergy, Optimal Dose +8

Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis

Gabrielle Pauli, Tina H. Larsen, S. Rak et al. · Journal of Allergy and Clinical Immunology · 2008 · 310 citations

Vaccination, Vaccine Development, Allergy +5

Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber

Friedrich Horak, Petra Zieglmayer, René Zieglmayer et al. · Journal of Allergy and Clinical Immunology · 2009 · 174 citations

Asthma, Allergy, Early Onset +9

Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen–induced rhinoconjunctivitis

A. Didier, Margitta Worm, Friedrich Horak et al. · Journal of Allergy and Clinical Immunology · 2011 · 166 citations

Asthma, Allergy, Allergy Medicine +7

Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: The importance of allergen-specific serum IgE

Linda Cox, Thomas B. Casale, Anjuli Nayak et al. · Journal of Allergy and Clinical Immunology · 2012 · 131 citations · Full text

Asthma, Allergen-specific Serum Ige, Us Study +9